Which has grown faster, PGNY or VRDN?

Over the past five years, VRDN grew revenue faster — PGNY at a 23.84% CAGR versus VRDN at 93.92%.

Is PGNY or VRDN more profitable?

PGNY runs the higher net margin — PGNY at 6.00% versus VRDN at -544.06%.

How have PGNY and VRDN total returns compared?

Over the past 5 years, PGNY delivered -14.83% and VRDN delivered 1.64% annualized total return. Past performance doesn't predict future results.

Progyny, Inc. (PGNY) vs Viridian Therapeutics, Inc. (VRDN)

A side-by-side comparison of Progyny, Inc. and Viridian Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

PGNY

Progyny, Inc.

$2.04B

$25.99HealthcareDelayed quote: Oct 6, 2026, 2:49 PM EDT

VRDN

Viridian Therapeutics, Inc.

$2.07B

$18.30HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT

Total return — PGNY vs VRDN

growth of $100 · dividends reinvested · last 7y

PGNY +62.2% (+7.2%/yr)VRDN +65.9% (+7.5%/yr)VRDN compounded faster over this window

PGNY VRDN

PGNY vs VRDN: by the numbers

•VRDN is the larger company ($2.07B vs $2.04B market cap).
•PGNY is profitable (6.00% net margin) while VRDN runs a net loss (-544.06%).
•VRDN grew revenue faster over the past five years (93.92% vs 23.84% CAGR).

Metrics side by side

Valuation

Metric	PGNY	VRDN
P/E ratio	28.25	N/A
Forward P/E	20.21	N/A
PEG ratio	4.22	N/A
P/S ratio	1.55	29.15
P/B ratio	4.49	3.68
EV / EBITDA	16.00	N/A
FCF yield	10.71%	N/A

Profitability

Metric	PGNY	VRDN
Gross margin	24.57%	99.55%
Operating margin	8.55%	-512.91%
Net margin	6.00%	-544.06%
ROE	17.35%	-58.45%
ROIC	15.47%	-39.18%

Growth (annualized)

Metric	PGNY	VRDN
Revenue CAGR (5Y)	23.84%	93.92%
EPS CAGR (5Y)	4.72%	N/A
FCF CAGR (5Y)	73.48%	N/A
Total return CAGR (5Y)	-14.83%	1.64%

Frequently asked

Which has grown faster, PGNY or VRDN?: Over the past five years, VRDN grew revenue faster — PGNY at a 23.84% CAGR versus VRDN at 93.92%.
Is PGNY or VRDN more profitable?: PGNY runs the higher net margin — PGNY at 6.00% versus VRDN at -544.06%.
How have PGNY and VRDN total returns compared?: Over the past 5 years, PGNY delivered -14.83% and VRDN delivered 1.64% annualized total return. Past performance doesn't predict future results.

Go deeper

Full PGNY analysis Full VRDN analysis Interactive comparison tool

Dig into the metrics

Progyny P/E ratio Progyny ROE Viridian Therapeutics ROE Progyny operating margin Viridian Therapeutics operating margin Progyny revenue growth Viridian Therapeutics revenue growth Progyny free cash flow Viridian Therapeutics free cash flow

Progyny & Viridian Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.